Commerzbank’s, Independence

Commerzbank’s Independence Hopes Hinge on Two Dates: July 8 Tender Count and August Profit Report

Published on 07/03/2026 at 21:13 | Redaktion boerse-global.de

UniCredit's revised tender offer for Commerzbank closed with disputed acceptance; Commerzbank shares near 52-week high as market weighs standalone strategy versus Italian bid.

UniCredit Offer for Commerzbank Ends: Stock Holds Near High as Strategy Debate Intensifies
Commerzbank Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The clock has finally run down on UniCredit’s revised tender offer for Commerzbank, with the extended acceptance period ending today, July 3. Yet the market is already looking past the July 8 announcement of the final tally to a different test: the bank’s own ability to deliver on an aggressive profit promise. Commerzbank shares are trading at €37.74, barely 2.86% below their 52-week high of €38.85, a level that underscores just how little investors appear to buy into the Italian lender’s overture.

The disputed acceptance math

UniCredit will publish the definitive acceptance figure on July 8, but the real battle is over what that number means. During the regular tender period, the Italian bank collected roughly 12.5% of Commerzbank’s equity. The breakdown is fiercely contested: about 11 percentage points came from other banks, only 1.3% from institutional investors and a mere 0.05% from retail holders. Independent shareholders – neither the German government nor UniCredit itself – appear to have tendered barely more than 1% of the stock, leaving the shareholder structure virtually unchanged.

UniCredit, however, calculates its position differently. Adding its direct holdings of nearly 27% to the tendered shares gives it about 39%, and including options and other instruments the bank claims control of up to 44%. The Commerzbank management board and supervisory board reject that arithmetic, arguing the offer lacks an adequate premium and a credible strategic plan. They have referred the matter to Germany’s BaFin, while the bank’s works council has filed a criminal complaint over suspected market manipulation. The outcome of those probes remains open.

The strategy showdown behind the price

The stock’s resilience – it has gained 34.31% over the past twelve months and sits 10.21% above its 200-day moving average of €34.24 – has become the chief evidence for the independence camp. If the implied swap value of UniCredit’s offer is demonstrably below the market price, the logic runs, then Commerzbank’s stand-alone plan is gaining credibility. The German government, holding roughly 12% of the shares, has rejected the bid and kept its stake unchanged.

Should investors sell immediately? Or is it worth buying Commerzbank?

But the market is also scrutinising the bank’s own promises. The “Momentum 2030” strategy targets a net return on equity of 21% by the end of the decade. In the first quarter of 2026, that figure stood at just 12.7%. Management aims to drive the cost-to-income ratio from 53% in Q1 to 43% through heavy investment in artificial intelligence, while committing to pay out the full net profit as dividends and buybacks provided the common equity tier 1 ratio stays above 13.5%. Net interest income held steady at €2 billion in the latest quarter, but recent European Central Bank rate cuts – the deposit rate now stands at 2.40% after June’s reduction – threaten that pillar.

Two paths, two dates

The bull case for Commerzbank rests on the stock’s technical strength and the low level of independent tender participation. With the relative strength index at 56.6, the shares are not overbought, and the 50-day moving average at €36.59 offers solid near-term support. A clean result on July 8 showing a minimal inflow from free-float holders would be read as a vote of confidence in the bank’s autonomous course.

The bear case, however, is not easily dismissed. UniCredit’s grip on a large block of shares, even if not yet a controlling one, remains a structural overhang. The Italian bank has said it does not expect the deal to close before 2027, leaving a long tail of regulatory uncertainty. A disappointing acceptance tally could push UniCredit to sweeten its offer or accumulate more shares, stirring fresh volatility. On the operational side, the high RoE target looks ambitious given the muted economic outlook for Germany’s Mittelstand, and any sign that Q2 profit might fall short of the €3.4 billion annual goal would invite profit-taking.

Commerzbank at a turning point? This analysis reveals what investors need to know now.

The calendar ahead

The next concrete catalyst arrives July 8, when UniCredit reports its own results and reveals the final acceptance count. That will clarify the immediate picture but not conclude the saga – the regulatory process will grind on for months or years. After that, all eyes turn to Commerzbank’s own second-quarter earnings on August 6. If costs hold near the 50% mark and revenue proves resilient, the bulls will have fresh ammunition. Should earnings stagnate, the support at €36.59 will be tested, and a break below that level could open the door to a slide toward the 200-day line near €34. For now, the market is pricing in neither a quick takeover nor a dramatic operating miss – but the margin for error on both fronts is narrowing.

Ad

Commerzbank Stock: New Analysis - 3 July

Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Commerzbank analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000CBK1001 | COMMERZBANK’S | boerse | 69682664 |